Homburger advises Grünenthal on the acquisition of Mestex

Grünenthal announced the acquisition of Mestex through the purchase of all of its shares and outstanding options.

Mestex is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee. The investigational medicine is currently concluding Phase II of clinical development and is about to enter Phase III.

Homburger advises Grünenthal on this matter as to all matters of Swiss law with a team including partner Andreas Müller (Corporate / M&A; Employment and Executive Compensation), counsel Peter Müller (Tax; Employment and Executive Compensation), associate Mirko Stiefel and junior associate Daniel Bötticher (both Corporate / M&A).

Freshfields Bruckhaus Deringer acts as global transaction counsel to Grünenthal.

Homburger advises Grünenthal on the acquisition of Mestex



Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram